These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 11072283)
1. Lipids and their role in coronary heart disease: what they do and how to manage them. Pradka LR Nurs Clin North Am; 2000 Dec; 35(4):981-91. PubMed ID: 11072283 [TBL] [Abstract][Full Text] [Related]
2. Does hypolipidemic therapy prevent coronary heart disease? Rifkind BM; Levy RI Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303 [No Abstract] [Full Text] [Related]
3. [Treatment of coronary arteriosclerosis depending on the nature of lipid metabolism disorders]. Anisimov VE; Semavin IE Klin Med (Mosk); 1975 Jul; 53(7):66-9. PubMed ID: 1206996 [No Abstract] [Full Text] [Related]
4. Diet and coronary heart disease: a review of the committee of diet and heart disease of the National Heart Foundation of Australia. Med J Aust; 1979 Sep; 2(6):294-307. PubMed ID: 392275 [No Abstract] [Full Text] [Related]
5. [What other effects do statins have except their effect on lipids?]. Tikkanen MJ Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256 [No Abstract] [Full Text] [Related]
6. Aggressive medical therapy for the prevention and treatment of coronary artery disease. Malloy MJ; Kane JP Adv Intern Med; 1997; 42():1-38. PubMed ID: 9048115 [No Abstract] [Full Text] [Related]
7. [Role of lipemia-lowering agents in the secondary prevention of myocardial infarct]. Tullio D Clin Ter; 1986 Feb; 116(3):221-35. PubMed ID: 3516543 [No Abstract] [Full Text] [Related]
8. Impact of multiple risk factors on coronary artery disease: beyond total cholesterol. Introduction. Gotto AM Am J Cardiol; 1998 Nov; 82(9A):1Q-2Q. PubMed ID: 9819097 [No Abstract] [Full Text] [Related]
9. Pharmacological treatment for hyperlipidaemia--the best preventive measure? Rosengren A; Swedberg K Eur Heart J; 1999 Feb; 20(4):245-6. PubMed ID: 10099914 [No Abstract] [Full Text] [Related]
10. [Hyperlipidemia, coronary disease and antilipemic drugs--do they help?]. Hansteen V Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3602-3. PubMed ID: 8539711 [No Abstract] [Full Text] [Related]
11. [Sulodexide in the therapy of vasculopathies]. Postiglione F; Pisani P; Gisonni P; Perrotta P; Gisonni A; Canciello M; Napolitano L; Brighina G; Ragno I; Salzano A Clin Ter; 1986 May; 117(3):223-31. PubMed ID: 3524974 [No Abstract] [Full Text] [Related]
12. Improvement in current approaches to lipid lowering. Ansell BJ Am Fam Physician; 2002 Mar; 65(5):783, 786-7. PubMed ID: 11898952 [No Abstract] [Full Text] [Related]
13. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors]. Broncel M; Balcerak M; Chojnowska-Jezierska J Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094 [TBL] [Abstract][Full Text] [Related]
14. [Study of hypolipemic effect of atheroid in ischemic heart disease associated with various types of hyperlipoproteinemia]. Zakharov VN Sov Med; 1978 Jan; (1):147-8. PubMed ID: 76342 [No Abstract] [Full Text] [Related]
15. Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)? Sherrod JP; Krist A J Fam Pract; 2001 Nov; 50(11):928. PubMed ID: 11711006 [No Abstract] [Full Text] [Related]
16. Dyslipidemia and coronary heart disease: management issues from Indian perspective. Gambhir DS; Gambhir JK; Sudha R Indian Heart J; 2000; 52(5):515-6, 617. PubMed ID: 11256772 [No Abstract] [Full Text] [Related]